# Top 10 comparator extracts from nccp-lung-guideline-full_cleaned.json

=== Ranked Comparator 1 (Extract #49, Control) — Score: 7 ===
control, or improved cost effectiveness compared with standard care alone (no involvement from specia
palliative care)?
Population: Patients with cancer (or specifically, lung cancer)
Intervention: Specialist Palliative care services
Comparison: Usual care (without palliative care)
Outcome: Symptom control, quality of life, cost-effectiveness, prognosis
Clinical question 2.8.2
Who should comprise the palliative care multidisciplinary team?
Population: Patients with cancer (or specifically, lung cancer)
Intervention: Multidisciplinary team care
Comparison: Usual care
Outcome: Symptom control, quality

=== Ranked Comparator 2 (Extract #137, Usual care) — Score: 6 ===
|Symptom control, quality of life, cost-effectiveness, prognosis
Row 6: Clinical question 2.8.2 Who should comprise the palliative care multidisciplinary team?|
Row 7: Population:|Patients with cancer (or specifically, lung cancer)
Row 8: Intervention:|Multidisciplinary team care
Row 9: Comparison:|Usual care
Row 10: Outcome:|Symptom control, quality of life, cost-effectiveness, prognosis Row 1: Clinical question 2.8.1 Does the involvement of specialist palliative care result in better quality of life for patient or family, sym control, or improved cost effectiveness compared with standard care alone (n

=== Ranked Comparator 3 (Extract #48, Control) — Score: 5 ===
adiation, no thoracic radio
Outcome: Survival, progression-free survival, response rate
| A National
the role of radio
C
py
otherapy
Clinic
other
cal Guideline
rapy Clinical question 2.8.1
Does the involvement of specialist palliative care result in better quality of life for patient or family, sym
control, or improved cost effectiveness compared with standard care alone (no involvement from specia
palliative care)?
Population: Patients with cancer (or specifically, lung cancer)
Intervention: Specialist Palliative care services
Comparison: Usual care (without palliative care)
Outcome: Symptom control

=== Ranked Comparator 4 (Extract #50, Control) — Score: 5 ===
: Symptom control, quality of life, cost-effectiveness, prognosis
Clinical question 2.8.2
Who should comprise the palliative care multidisciplinary team?
Population: Patients with cancer (or specifically, lung cancer)
Intervention: Multidisciplinary team care
Comparison: Usual care
Outcome: Symptom control, quality of life, cost-effectiveness, prognosis
mptom
alist
122 | Diagnosis, staging and treatment of | A Natio
Appendix 3: Summary of the tools to assist in the impleme
this National Clinical Guideline
NCCP. National Clinical Guidelines for Cancer – Methodology Manual.
National Cancer Control Prog

=== Ranked Comparator 5 (Extract #68, Control) — Score: 5 ===
views of RCTs, or RCTs with a very low risk of bias.
1+ Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias.
1- Meta-analyses, systematic reviews, or RCTs with a high risk of bias.
2++ High quality systematic reviews of case control or cohort studies.
High quality case control or cohort studies with a very low risk of confounding or bias and a high
probability that the relationship is causal.
2+ Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate
probability that the relationship is causal.
2- Case control or cohort studies

=== Ranked Comparator 6 (Extract #69, Control) — Score: 5 ===
alyses, systematic reviews, or RCTs with a high risk of bias.
2++ High quality systematic reviews of case control or cohort studies.
High quality case control or cohort studies with a very low risk of confounding or bias and a high
probability that the relationship is causal.
2+ Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate
probability that the relationship is causal.
2- Case control or cohort studies with a high risk of confounding or bias and a significant risk that the
relationship is not causal.
3 Non-analytic studies (e.g. case reports, case

=== Ranked Comparator 7 (Extract #90, Control) — Score: 5 ===
veness compared with standard care alone (no involvement from specialist palliative care)?|
Row 2: Population:|Patients with cancer (or specifically, lung cancer)
Row 3: Intervention:|Specialist Palliative care services
Row 4: Comparison:|Usual care (without palliative care)
Row 5: Outcome:|Symptom control, quality of life, cost-effectiveness, prognosis
Row 6: Clinical question 2.8.2 Who should comprise the palliative care multidisciplinary team?|
Row 7: Population:|Patients with cancer (or specifically, lung cancer)
Row 8: Intervention:|Multidisciplinary team care
Row 9: Comparison:|Usual care
Row 1

=== Ranked Comparator 8 (Extract #91, Control) — Score: 5 ===
ost-effectiveness, prognosis
Row 6: Clinical question 2.8.2 Who should comprise the palliative care multidisciplinary team?|
Row 7: Population:|Patients with cancer (or specifically, lung cancer)
Row 8: Intervention:|Multidisciplinary team care
Row 9: Comparison:|Usual care
Row 10: Outcome:|Symptom control, quality of life, cost-effectiveness, prognosis Row 1: Clinical question 2.8.1 Does the involvement of specialist palliative care result in better quality of life for patient or family, sym control, or improved cost effectiveness compared with standard care alone (no involvement from specia palliat

=== Ranked Comparator 9 (Extract #92, Control) — Score: 5 ===
w 8: Intervention:|Multidisciplinary team care
Row 9: Comparison:|Usual care
Row 10: Outcome:|Symptom control, quality of life, cost-effectiveness, prognosis Row 1: Clinical question 2.8.1 Does the involvement of specialist palliative care result in better quality of life for patient or family, sym control, or improved cost effectiveness compared with standard care alone (no involvement from specia palliative care)?
Row 2: Population:
Row 3: Intervention:
Row 4: Comparison:
Row 5: Outcome:
Row 6: Clinical question 2.8.2 Who should comprise the palliative care multidisciplinary team?
Row 7: Population

=== Ranked Comparator 10 (Extract #106, Control) — Score: 5 ===
s with a very low risk of bias.
Row 2: 1+|Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias.
Row 3: 1-|Meta-analyses, systematic reviews, or RCTs with a high risk of bias.
Row 4: 2++|High quality systematic reviews of case control or cohort studies. High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal.
Row 5: 2+|Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal.
Row 6: 2-|Case control or

